Increased motility and invasiveness in tumor cells that survive 10 Gy irradiation

Cell Structure and Function

Volumn 34, Issue 2, 2009, Pages 89-96

  Tsutsumi, Kaori ^a,b   Tsuda, Masumi ^b   Yazawa, Natsuka ^a   Nakamura, Hirotaka ^a   Ishihara, Seiichiro ^a   Haga, Hisashi ^a   Yasuda, Motoaki ^a   Yamazaki, Rie ^a   Shirato, Hiroki ^b   Kawaguchi, Hideaki ^b   Nishioka, Takeshi ^a   Ohba, Yusuke ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell motility; Invasion; MMP; Non small cell lung cancer; Radiotherapy

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; INTEGRIN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PAXILLIN; VINCULIN;

ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IRRADIATION; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; TUMOR CELL; ZYMOGRAPHY;

ANTIGENS, CD29; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FOCAL ADHESION KINASE 1; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PAXILLIN; RADIATION DOSAGE; VINCULIN;

EID: 70350676371     PISSN: 03867196     EISSN: 13473700     Source Type: Journal    
DOI: 10.1247/csf.09006     Document Type: Article

References (22)

1. Alexandrova, M.L., Bochev, P.G., and Markova, V.I. 2007. Inhibitory and enhancing effects of piroxicam on whole blood chemiluminescence. Luminescence, 22: 97-104.
2. Brinckerhoff, C.E., Rutter, J.L., and Benbow, U. 2000. Interstitial collagenases as markers of tumor progression. Clin. Cancer Res., 6: 4823-4830.
3. Chambers, A.F. and Matrisian, L.M. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270.
4. Egeblad, M. and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174.
5. Fidler, I.J., Kim, S.J., and Langley, R.R. 2007. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J. Cell Biochem., 101: 927-936. (Pubitemid 47040873)
6. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., and Thun, M.J. 2006. Cancer statistics, 2006. CA Cancer J. Clin., 56: 106-130.
7. Jung, J.W., Hwang, S.Y., Hwang, J.S., Oh, E.S., Park, S., and Han, I.O. 2007. Ionising radiation induces changes associated with epithelialmesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur. J. Cancer, 43: 1214-1224.
8. Nagase, H., Visse, R., and Murphy, G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res., 69: 562-573.
9. Naito, Y., Kubota, K., Nihei, K., Fujii, T., Yoh, K., Niho, S., Goto, K., Ohmatsu, H., Saijo, N., and Nishiwaki, Y. 2008. Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer. J. Thorac. Oncol., 3: 617-622.
10. Nelson, A.R., Fingleton, B., Rothenberg, M.L., and Matrisian, L.M. 2000. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 18: 1135-1149.
11. Nishioka, T., Yasuda, M., Tsutsumi, K., Haga, H., and Shirato, H. 2007. Matrix metalloproteinases: up-regulated in subclones that survived 10-Gy irradiation. Radiat. Med., 25: 430-431.
12. Onishi, H., Araki, T., Shirato, H., Nagata, Y., Hiraoka, M., Gomi, K., Yamashita, T., Niibe, Y., Karasawa, K., Hayakawa, K., Takai, Y., Kimura, T., Hirokawa, Y., Takeda, A., Ouchi, A., Hareyama, M., Kokubo, M., Hara, R., Itami, J., and Yamada, K. 2004. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer, 101: 1623-1631.
13. Palazzi, M., Orlandi, E., Bossi, P., Pignoli, E., Potepan, P., Guzzo, M., Franceschini, M., Scaramellini, G., Cantu, G., Licitra, L., Olmi, P., and Tomatis, S. 2009. Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int. J. Radiat. Oncol. Biol. Phys., 74: 774-780.
14. Peters, L.J., Brock, W., and Johnson, T. 1985. Predicting radiocurability. Cancer, 55: 2118-2122.
15. Peters, L.J., Withers, H.R., Thames, H.D., Jr., and Fletcher, G.H. 1982. Tumor radioresistance in clinical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 8: 101-108.
16. Petit, V., Boyer, B., Lentz, D., Turner, C.E., Thiery, J.P., and Valles, A.M. 2000. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J. Cell Biol., 148: 957-970. (Pubitemid 30680944)
17. Sauter, W., Rosenberger, A., Beckmann, L., Kropp, S., Mittelstrass, K., Timofeeva, M., Wolke, G., Steinwachs, A., Scheiner, D., Meese, E., Sybrecht, G., Kronenberg, F., Dienemann, H., Chang-Claude, J., Illig, T., Wichmann, H.E., Bickeboller, H., and Risch, A. 2008. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol. Biomarkers Prev., 17: 1127-1135.
18. Spira, A. and Ettinger, D.S. 2004. Multidisciplinary management of lung cancer. N. Engl. J. Med., 350: 379-392.
19. Tarin, D. and Matsumura, Y. 1994. Recent advances in the study of tumour invasion and metastasis. J. Clin. Pathol., 47: 385-390.
20. Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H., and Sabe, H. 2002. Localized suppression of RhoA activity by Tyr31/ 118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol., 159: 673-683.
21. Tsutsumi, K., Yasuda, M., and Nishioka, T. 2006. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line. Cell Struct. Funct., 31: 47-52.
22. Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., and Wick, W. 2001. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res., 61: 2744-2750. (Pubitemid 32685864)